Left Ventricular Noncompaction 3 C3152137
Left Ventricular Noncompaction 3 is a rare genetic heart condition causing abnormal heart muscle development. The left ventricle may not pump blood effectively. Care involves heart medications, lifestyle monitoring, and sometimes surgical interventions.
Key facts at a glance
- ICD-10
- I78.0
- ICD-11
- BA00.0
- Body system
- cardiovascular
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Ventricular arrhythmia
Chest discomfort or palpitations
(cardiovascular)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Dyspnea
(cardiovascular)Reduced exercise tolerance
(cardiovascular)Nocturnal paroxysmal dyspnea
(cardiovascular)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Disease management and monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Diuretic Therapy
Loop or thiazide diuretics to manage volume overload, reduce pulmonary congestion, and alleviate symptoms of heart failure. Used as part of comprehensive fluid management strategy.
Ambulatory Arrhythmia Monitoring
Extended cardiac monitoring using Holter monitors or event recorders to detect paroxysmal arrhythmias, assess burden of atrial fibrillation, and guide antiarrhythmic therapy decisions.
Additional treatment options
Cardiac Resynchronization Therapy
Biventricular pacing device to coordinate ventricular contractions in patients with wide QRS and dyssynchronous contraction patterns. May improve symptoms and cardiac function in select LVNC patients.
procedureSodium and Fluid Restriction
Dietary modification limiting sodium intake to less than 2-3 grams daily along with appropriate fluid restrictions to minimize fluid retention and reduce cardiac workload. Includes patient education on reading food labels.
dietaryCoenzyme Q10 Supplementation
Adjunctive therapy with CoQ10 to potentially improve myocardial energy metabolism and reduce oxidative stress. May provide symptomatic benefit in some heart failure patients as complementary support.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Left Ventricular Noncompaction 3 C3152137?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Left Ventricular Noncompaction 3 C3152137. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy